U.S. Medical Equipment Stock News

In early August 2026, Weis Markets, Inc. reported past second-quarter results showing sales of US$1,270.86 million and revenue of US$1,275.31 million, with net income of US$22.86 million and basic earnings per share from continuing operations of US$0.92, all compared with the prior year period. For the first half of the year ended June 27, 2026, the company’s higher sales and revenue were accompanied by increased net income of US$50.71 million and basic earnings per share from continuing...

In the past week, Gibraltar Industries, Inc. reported second-quarter 2026 results showing sales rising to US$509.55 million from US$309.52 million a year earlier, while net income fell to US$8.19 million from US$26 million and earnings per share weakened on both a quarterly and year-to-date basis. At the same time, the company reiterated its full-year 2026 guidance, projecting consolidated net sales of US$1.76 billion to US$1.83 billion and GAAP diluted EPS of US$2.40 to US$2.80,...

In late July 2026, Bandwidth Inc. reported second‑quarter 2026 results showing year‑over‑year sales growth to US$219.9 million and a move to US$2.39 million in net income, raised full‑year 2026 revenue guidance to US$900 million–US$910 million, amended its credit agreement to increase permitted restricted payments, continued share repurchases, and announced the planned year‑end retirement of General Counsel and Secretary R. Brandon Asbill. A key insight is that Bandwidth is pairing improved...

In the past week, Everest Group, Ltd. filed a US$300.72 million shelf registration for 812,000 common shares related to an ESOP offering, alongside reporting second-quarter 2026 revenue of US$3.96 billion and net income of US$559 million. These capital moves, together with ongoing share repurchases under a long-running buyback and the launch of Annapurna Re, underline Everest’s emphasis on flexible capital management and underwriting-focused earnings. We’ll now examine how the strong...

Commerce.com (CMRC) is back in focus after a mixed set of August 6 updates. The company reported a return to quarterly profitability, announced fresh client partnerships, and at the same time lowered its full year 2026 revenue guidance. See our latest analysis for Commerce.com. Commerce.com’s share price has fallen 29.1% over the past week and is down 45.3% year to date, while the 1-year total shareholder return has declined 49.1%. This suggests that recent earnings progress has not yet eased...

Integra LifeSciences Holdings Corporation reported past second-quarter 2026 results showing sales of US$418.76 million and net income of US$4.48 million, a shift from a large net loss a year earlier. The company also modestly reduced its full-year 2026 reported revenue outlook due to currency headwinds while reaffirming its organic revenue growth and adjusted EPS guidance, underscoring the effect of foreign exchange on reported performance. We’ll now examine how this earnings improvement,...

Recently, analyst reports highlighted that TJX Companies raised its FY2027 guidance, pointing to 3%–4% comparable sales growth and higher EPS expectations, while also receiving a Zacks Rank #2 and a Momentum Style Score of B amid upward earnings estimate revisions for the current and next fiscal years. This combination of stronger earnings expectations and improved momentum signals that investors are increasingly focused on whether TJX’s off-price model can consistently translate robust...

In late July 2026, UDR, Inc. reported second-quarter 2026 results showing net income of US$69.04 million and basic earnings per share from continuing operations of US$0.21, both higher than the same period a year earlier, while revenue was broadly unchanged at about US$425.40 million. Alongside these results, UDR raised its full-year 2026 net income guidance per diluted share to a range of US$1.03 to US$1.11, signaling management’s increased confidence in the company’s earnings...

Recent commentary around Chewy (CHWY) has sharpened focus on the stock’s valuation and profitability pressures, drawing fresh attention as investors weigh its mixed return history against ongoing interest in pet e commerce. See our latest analysis for Chewy. Chewy’s recent 1 month share price return of 12.69% and 7 day share price return of 4.12% suggest some momentum is returning, although the year to date share price return has declined 29.74% and the 5 year total shareholder return has...

Why Etsy Stock Is Back in Focus After Q2 Earnings Etsy (ETSY) is in the spotlight after second quarter results on August 5, 2026, along with a raised full year outlook, a new US$2b share repurchase plan, and a workforce restructuring. See our latest analysis for Etsy. The recent Q2 report, higher full year outlook and new US$2b buyback have come alongside a strong run in Etsy's share price, with a 90 day share price return of 42.92% and a 1 year total shareholder return of 40.45%, while the 5...

FB Financial stock has delivered a strong 86.8% return over the past three years, while the latest Excess Returns intrinsic value estimate suggests the shares trade at a discount to fair value even though broader valuation checks lean cautious. That mix leaves investors weighing a stock that has already performed well against signals that it may still be pricing in a margin of safety. FB Financial's 86.8% return over three years points to a stock that has already rewarded shareholders and...

Boardroom Changes Put Kohl's Governance In Focus Kohl's (KSS) is back on investor radars after a boardroom reshuffle, with long serving director John E. Schlifske retiring as independent Chair and Wendy Arlin stepping into the role on July 28, 2026. The company also added experienced consumer brands executive Niren Chaudhary to its Board, giving investors fresh information to consider around governance, oversight and how board composition might influence future decisions at the retailer. See...

Helmerich & Payne (HP) drew fresh attention after reporting fiscal Q3 2026 results that came in above its own guidance, along with a higher full-year North America rig-count outlook and a continued focus on debt reduction. See our latest analysis for Helmerich & Payne. At a share price of $37.10, Helmerich & Payne has seen a 30 day share price return of 11.31% and a year to date share price return of 23.91%, while the 1 year total shareholder return of 122.62% contrasts with a modest 3 year...

Carlisle Companies dividend hike and guidance raise put capital returns in focus Carlisle Companies (CSL) has drawn fresh attention after reporting record second quarter results, raising full year revenue guidance to mid single digit growth and lifting its 2026 share repurchase target to $1.2b. At the same time, the Board approved a 14% increase in the regular quarterly dividend to $1.25 per share, or $5 on an annualized basis. The dividend is payable on September 1, 2026, to shareholders of...

Why QuinStreet’s latest earnings and M&A comments matter for investors QuinStreet (QNST) has put itself firmly on investors’ radars after reporting detailed fourth quarter and full year 2026 results, alongside new fiscal 2027 revenue guidance and fresh commentary on potential acquisitions. The company reported fourth quarter sales of US$373.88 million and net income of US$19.11 million. For the full 2026 fiscal year, sales were US$1.29b with net income of US$81.24 million, according to the...

AtriCure (ATRC) has drawn investor attention after multiple insider share sales. This followed a quarter in which the company reported 13% second quarter revenue growth, a return to net income, and raised full year guidance. See our latest analysis for AtriCure. AtriCure’s recent insider sales come against a backdrop of strong share price momentum, with a 57.38% 90 day share price return and 20.74% 30 day share price return, while the 5 year total shareholder return is still down 43.49%. If...

GH Research PLC recently reported second-quarter 2026 results showing a net loss of US$15.15 million, up from US$9.29 million a year earlier, with basic and diluted loss per share from continuing operations rising to US$0.23 from US$0.15. For the first half of 2026, the company’s net loss expanded to US$34.11 million versus US$20.10 million in the prior-year period, highlighting a meaningful increase in cash burn and pressure on its financial profile. We’ll now examine how this widening net...

Pediatrix Medical Group has delivered a strong 89.0% share price return over the past year, yet the stock still screens as cheap on several valuation checks. This raises the question of how much of the recent improvement is already reflected in the price. The recent share price drop following earnings news adds another layer for investors weighing whether the current level still offers value. Over the last 1 year, Pediatrix Medical Group shares are up 89.0%. This means anyone looking at the...

Axsome Therapeutics event context and recent stock performance Axsome Therapeutics (AXSM) continues to draw investor attention as it advances therapies for central nervous system disorders, including approved treatments for depression, excessive daytime sleepiness, and migraine, alongside multiple late stage clinical programs. The stock last closed at US$212.74 on 7 August 2026. Over the past month the share price declined 9%, while the past 3 months show a smaller fall of 1.7%, leaving the...

What the latest earnings mean for Organogenesis Holdings stock Organogenesis Holdings (ORGO) is back in focus after second quarter results showed sharply lower revenue and a much wider net loss, alongside a deeper revenue outlook cut and a planned US$75 million equity raise. The earnings update matters for you because it reshapes expectations on cash generation, dilution risk and how much flexibility Organogenesis Holdings might have to fund its wound care portfolio, including products like...

Weaker US job numbers, softer wage growth, and fading odds of a September Fed hike have put major bank stocks under a sharper spotlight. When the labor market cools and rate expectations shift, the ripple effects can matter for profits, loan quality, and investor confidence. This article walks through three large US bank stocks that appear especially exposed to this latest data, and explains why that may give you a reason to reassess your own banking exposure today. Wells Fargo...

Why the new First Plus mandate matters for SS&C Technologies SS&C Technologies Holdings (SSNC) has been selected by First Plus Asset Management Pte. Ltd. to support around US$200 million in cross-border assets across Asia, covering transfer agency, order management, execution, and investment accounting. This new client adds to SS&C Technologies Holdings' global operations footprint and gives investors fresh information about how its integrated service model is being used across multiple Asian...

Joby Aviation (JOBY) is back in focus after a busy week, with the stock reacting to raised 2026 revenue guidance, a new 45,000 square foot Texas facility, and a fresh vertiport partnership with Atoms. See our latest analysis for Joby Aviation. The latest facility opening and vertiport partnership have come alongside a 7 day share price return of 20.84% and a 1 day move of 4.98%. However, Joby Aviation’s year to date share price return is still down 39.83% and the 1 year total shareholder...

Insight Enterprises stock has gained 77.8% year to date, and current valuation checks suggest the market price still sits below an intrinsic value estimate based on a Discounted Cash Flow (DCF), with earnings multiples telling a similar story. Year to date, Insight Enterprises is up 77.8%, which puts extra focus on whether recent gains already reflect the company’s long term cash flow potential. Future revenue and cash flow growth can support the current share price, while any pressure on...